Emisphere Technologies, Inc. (EMIS)
-OTC BB 0.17 
0.00(2.35%) 2:07PM EDT
| Prev Close: | 0.17 |
|---|
| Open: | 0.16 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | -0.84 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.16 - 0.19 |
|---|
| 52wk Range: | 0.05 - 0.38 |
|---|
| Volume: | 15,816 |
|---|
| Avg Vol (3m): | 55,897 |
|---|
| Market Cap: | 10.07M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.06 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to aEDGAR Online(Fri, May 31)
- EMISPHERE TECHNOLOGIES INC FinancialsEDGAR Online Financials(Tue, May 21)
- Emisphere Technologies, Inc. Announces Financial Results for Quarter Ended March 31, 2013GlobeNewswire(Wed, May 15)
- EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online(Wed, May 15)
- Emisphere Technologies, Inc. Announces First Quarter 2013 Earnings Conference CallGlobeNewswire(Mon, May 13)
- EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial StatemEDGAR Online(Thu, May 9)
- Novo Nordisk and EMIS Modify DealZacks(Wed, May 1)
- EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct FinanEDGAR Online(Mon, Apr 29)
- Emisphere Announces Restructuring of MHR ObligationsGlobeNewswire(Mon, Apr 29)
- Emisphere Announces Amendment to Oral GLP-1 Development License Agreement With Novo NordiskGlobeNewswire(Mon, Apr 29)
- Emisphere Technologies, Inc. Announces Financial Results for Fourth Quarter and Year Ended December 31, 2012GlobeNewswire(Thu, Mar 28)
- EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements anEDGAR Online(Thu, Mar 28)
- Icahn Foe Rachesky Joins Mentor Attack on Navistarat Bloomberg(Mon, Mar 4)
- EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PriEDGAR Online(Thu, Jan 17)
- EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Other EventsEDGAR Online(Thu, Jan 3)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Emisphere Technologies, Inc., a biopharmaceutical company, focuses on the delivery of therapeutic molecules, nutritional supplements, and pharmaceutical compounds using its Eligen technology.
View More